Randomised, double-blind, placebo-controlled clinical trial for evaluating the efficacy of intracoronary injection of autologous bone marrow mononuclear cells in the improvement of the ventricular function in patients with idiopathic dilated myocardiopathy: a study protocol

MLA

Miguel Romero, et al. “Randomised, Double-Blind, Placebo-Controlled Clinical Trial for Evaluating the Efficacy of Intracoronary Injection of Autologous Bone Marrow Mononuclear Cells in the Improvement of the Ventricular Function in Patients with Idiopathic Dilated Myocardiopathy: A Study Protocol.” BMC Cardiovascular Disorders, vol. 19, Aug. 2019. EBSCOhost, https://doi.org/10.1186/s12872-019-1182-4.

APA

Miguel Romero, José Suárez-de-Lezo, Concha Herrera, Manuel Pan, José López-Aguilera, Flor Baeza-Garzón, Francisco Javier Hidalgo-Lesmes, Olga Fernández-López, Juliana Martínez-Atienza, Eva Cebrián, Vanesa Martín-Palanco, Rosario Jiménez-Moreno, Rosario Gutiérrez-Fernández, Sonia Nogueras, Maria Dolores Carmona, Soledad Ojeda, Natividad Cuende, & Rosario Mata. (2019). Randomised, double-blind, placebo-controlled clinical trial for evaluating the efficacy of intracoronary injection of autologous bone marrow mononuclear cells in the improvement of the ventricular function in patients with idiopathic dilated myocardiopathy: a study protocol. BMC Cardiovascular Disorders, 19. https://doi.org/10.1186/s12872-019-1182-4

Chicago

Miguel Romero, José Suárez-de-Lezo, Concha Herrera, Manuel Pan, José López-Aguilera, Flor Baeza-Garzón, Francisco Javier Hidalgo-Lesmes, et al. 2019. “Randomised, Double-Blind, Placebo-Controlled Clinical Trial for Evaluating the Efficacy of Intracoronary Injection of Autologous Bone Marrow Mononuclear Cells in the Improvement of the Ventricular Function in Patients with Idiopathic Dilated Myocardiopathy: A Study Protocol.” BMC Cardiovascular Disorders 19 (August). doi:10.1186/s12872-019-1182-4.